Anticentromere Autoantibodies in Patients without Raynaud's Disease or Systemic Sclerosis
- 28 February 1999
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 90 (2) , 182-189
- https://doi.org/10.1006/clim.1998.4643
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Longitudinal Study of Anticentromere and Antitopoisomerase-I IsotypesClinical Immunology and Immunopathology, 1995
- Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA studyClinical and Experimental Immunology, 1994
- Anticentromere AutoantibodiesArthritis & Rheumatism, 1994
- Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosisArthritis & Rheumatism, 1992
- Prognostic significance of anticentromere antibodies and anti–topoisomerase i antibodies in Raynaud's disease. A prospective studyArthritis & Rheumatism, 1991
- Anticytoskeletal autoantibody to microfilament anchorage sites recognizes novel focal contact proteins.Journal of Clinical Investigation, 1987
- Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.Journal of Clinical Investigation, 1986
- Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.Annals of the Rheumatic Diseases, 1982
- The CREST syndrome: A distinct serologic entity with anticentromere antibodiesThe American Journal of Medicine, 1980
- Diversity of antinuclear antibodies in progressive systemic sclerosisArthritis & Rheumatism, 1980